Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Originally published as JCO Early Release 10.1200/JCO.2008.17.0795 on March 2 2009

Journal of Clinical Oncology, Vol 27, No 11 (April 10), 2009: pp. 1844-1849
© 2009 American Society of Clinical Oncology.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nowakowski, G. S.
Right arrow Articles by Kay, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nowakowski, G. S.
Right arrow Articles by Kay, N. E.
Related Articles
Right arrowRelated Correspondence
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Leukemia and Bone Marrow Transplantation

Percentage of Smudge Cells on Routine Blood Smear Predicts Survival in Chronic Lymphocytic Leukemia

Grzegorz S. Nowakowski, James D. Hoyer, Tait D. Shanafelt, Clive S. Zent, Timothy G. Call, Nancy D. Bone, Betsy LaPlant, Gordon W. Dewald, Renee C. Tschumper, Diane F. Jelinek, Thomas E. Witzig, Neil E. Kay

From the Department of Internal Medicine, Division of Hematology; Department of Laboratory Medicine and Pathology, Division of Hematopathology and Division of Cytogenetics; Health Sciences Research, Division of Biostatistics; and Department of Immunology, Mayo Clinic, Rochester, MN.

Corresponding author: Grzegorz S. Nowakowski, MD, Mayo Clinic, 200 First St SW, Rochester, MN 55905; e-mail: Nowakowski.Grzegorz{at}mayo.edu.

Purpose Smudge cells are ruptured chronic lymphocytic leukemia (CLL) cells appearing on the blood smears of CLL patients. Our recent findings suggest that the number of smudge cells may have important biologic correlations rather than being only an artifact of slide preparation. In this study, we evaluated whether the smudge cell percentage on a blood smear predicted survival of CLL patients.

Patients and Methods We calculated smudge cell percentages (ratio of smudged to intact cells plus smudged lymphocytes) on archived blood smears from a cohort of previously untreated patients with predominantly early-stage CLL enrolled onto a prospective observational study. The relationship between percentage of smudge cells, patient survival, and other prognostic factors was explored.

Results Between 1994 and 2002, 108 patients were enrolled onto the study and had archived blood smears available for review; 80% of patients had Rai stage 0 or I disease. The median smudge cell percentage was 28% (range, 1% to 75%). The percentage of smudge cells was lower in CD38+ versus CD38 patients (P = .019) and in Zap70-positive versus Zap70-negative patients (P = .028). Smudge cell percentage as a continuous variable was associated with prolonged survival (P = .042). The 10-year survival rate was 50% for patients with 30% or less smudge cells compared with 80% for patients with more than 30% of smudge cells (P = .015). In multivariate analysis, the percentage of smudge cells was an independent predictor of overall survival.

Conclusion Percentage of smudge cells on blood smear is readily available and an independent factor predicting overall survival in CLL.

Supported in part by Grant No. CA95241 from the National Cancer Institute, National Institutes of Health, and philanthropic support from the Donner Family Foundation.

Presented in part at the 12th Annual International Workshop for Chronic Lymphocytic Leukemia, September 14-16, 2007, London, United Kingdom.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Correspondence

  • Smudge Cells, Serum Albumin, and Prognosis in B-Cell Chronic Lymphocytic Leukemia
    Ronald S. Go
    JCO 2009 27: 44 [Full Text]


This article has been cited by other articles:


Home page
JCOHome page
R. S. Go
Smudge Cells, Serum Albumin, and Prognosis in B-Cell Chronic Lymphocytic Leukemia
J. Clin. Oncol., August 1, 2009; 27(22): e44 - e44.
[Full Text] [PDF]


Home page
JCOHome page
G. S. Nowakowski, T. D. Shanafelt, S. Schwager, and N. E. Kay
Reply to R.S. Go
J. Clin. Oncol., August 1, 2009; 27(22): e45 - e45.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online